Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
15.34
-0.22 (-1.41%)
At close: Jul 15, 2026, 4:00 PM EDT
15.64
+0.30 (1.96%)
After-hours: Jul 15, 2026, 6:54 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $783.75 million as of July 15, 2026. Its market cap has increased by 242.80% in one year.
Market Cap
783.75M
Enterprise Value
664.99M
1-Year Change
242.80%
Ranking
Category
Stock Price
$15.34
Market Cap Chart
Since March 16, 1993, Tenax Therapeutics's market cap has increased from $110.17M to $783.75M, an increase of 611.38%. That is a compound annual growth rate of 6.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 783.75M | 58.48% |
| Dec 31, 2025 | 494.55M | 126.39% |
| Dec 31, 2024 | 218.45M | 3,233.86% |
| Dec 29, 2023 | 6.55M | 31.60% |
| Dec 30, 2022 | 4.98M | -81.01% |
| Dec 31, 2021 | 26.21M | 11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 812.03M |
| Oculis Holding AG | 795.31M |
| Aura Biosciences | 794.71M |
| Zevra Therapeutics | 777.95M |
| Neurogene | 774.16M |
| Aclaris Therapeutics | 768.15M |
| Climb Bio | 768.15M |
| Immix Biopharma | 767.43M |